全文获取类型
收费全文 | 2215篇 |
免费 | 124篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 56篇 |
妇产科学 | 15篇 |
基础医学 | 411篇 |
口腔科学 | 43篇 |
临床医学 | 198篇 |
内科学 | 454篇 |
皮肤病学 | 23篇 |
神经病学 | 141篇 |
特种医学 | 291篇 |
外科学 | 185篇 |
综合类 | 31篇 |
预防医学 | 134篇 |
眼科学 | 144篇 |
药学 | 120篇 |
中国医学 | 2篇 |
肿瘤学 | 94篇 |
出版年
2022年 | 14篇 |
2021年 | 34篇 |
2020年 | 14篇 |
2019年 | 22篇 |
2018年 | 26篇 |
2017年 | 29篇 |
2016年 | 23篇 |
2015年 | 40篇 |
2014年 | 54篇 |
2013年 | 60篇 |
2012年 | 91篇 |
2011年 | 68篇 |
2010年 | 67篇 |
2009年 | 53篇 |
2008年 | 86篇 |
2007年 | 67篇 |
2006年 | 69篇 |
2005年 | 82篇 |
2004年 | 72篇 |
2003年 | 64篇 |
2002年 | 74篇 |
2001年 | 58篇 |
2000年 | 48篇 |
1999年 | 47篇 |
1998年 | 55篇 |
1997年 | 69篇 |
1996年 | 59篇 |
1995年 | 59篇 |
1994年 | 53篇 |
1993年 | 40篇 |
1992年 | 44篇 |
1991年 | 39篇 |
1990年 | 30篇 |
1989年 | 41篇 |
1988年 | 52篇 |
1987年 | 38篇 |
1986年 | 51篇 |
1985年 | 47篇 |
1984年 | 31篇 |
1983年 | 35篇 |
1982年 | 29篇 |
1981年 | 26篇 |
1980年 | 26篇 |
1979年 | 25篇 |
1978年 | 18篇 |
1977年 | 25篇 |
1976年 | 25篇 |
1975年 | 21篇 |
1973年 | 12篇 |
1969年 | 11篇 |
排序方式: 共有2348条查询结果,搜索用时 0 毫秒
1.
Judith Brock Andreas Schmid Thomas Karrasch Petra Pfefferle Jutta Schlegel Inga Busse Annette Hauenschild Barbara Schmidt Maria Koukou Efthymia Arapogianni Andreas Schultz Miriam Thomalla Secil Akinci Johannes Kruse Winfried Padberg Andreas Schffler Jens Albrecht 《Clinical endocrinology》2019,91(3):400-410
2.
3.
Intracranial circulation: pulse-sequence considerations in three- dimensional (volume) MR angiography 总被引:2,自引:0,他引:2
The technique and feasibility of magnetic resonance (MR) angiography of intracranial vessels were studied in 35 healthy volunteers. Variations in image orientation, repetition time (TR), and flip angle were evaluated to determine their effects on flow-related enhancement. Gradient modifications--including echo time (TE), motion compensation, bandwidth, and field of view--were also studied in an effort to reduce motion-induced phase shifts. Results indicated that a FISP (fast imaging with steady precession) sequence with a TR of 50 msec, TE of 15 msec, velocity compensation in the read and section-select directions, acceleration compensation in the read direction, anisotropic volume, and a 1.25-mm partition thickness produced three-dimensional angiographic MR images that were accurate and reproducible in the depiction of the major intracranial vessels. Difficulties with field of view, persistent signal void secondary to higher-order motion, and spatial resolution remain major problems requiring additional study. 相似文献
4.
5.
M F Matangi J A Strickland J J Burgess E F Busse 《The Canadian journal of cardiology》1987,3(7):342-344
Operative mortality, postoperative morbidity and follow up data were analyzed retrospectively from 122 consecutive patients, over 65 years old undergoing elective aortocoronary bypass grafting for symptomatic relief of angina pectoris at the Plains Health Centre, Regina, Saskatchewan, from January 1980 to December 1985. There were two in-hospital deaths (operative mortality 1.6%). Definite perioperative myocardial infarction occurred in 12 patients (9.8%). The 120 survivors were followed for a mean of 32 months. There were three deaths during follow-up, giving a five-year probability of survival of 93%. Twenty-three clinical events (including deaths) occurred during follow-up, giving a five-year probability of event free survival of 72%. Ninety percent of patients say they are pleased with their operation. Seventy-eight percent are currently angina free. These data illustrate the effectiveness of aortocoronary bypass grafting in low risk elderly patients with symptomatic coronary artery disease. 相似文献
6.
7.
8.
9.
M J Buxton S D Sullivan L F Andersson C J Lamm B Liljas W W Busse S Pedersen K B Weiss 《The European respiratory journal》2004,24(4):568-574
Early intervention with budesonide is an effective strategy for mild persistent asthma, which has been shown to provide additional clinical benefits at a low incremental cost using USA cost data. The present authors analysed whether this strategy would be cost-effective using cost data for other countries. Based on the 3-yr prospective, randomised, double-blind inhaled Steroid Treatment As Regular Therapy (START) in early asthma study (comparing budesonide and placebo combined with usual asthma therapy), the cost-effectiveness was estimated separately for eight different countries, from both healthcare payer and societal perspectives, of adding budesonide to usual asthma therapy. Local unit costs were applied to data for the total trial population. Incremental cost-effectiveness ratios (ICER) were estimated as cost per symptom-free day (SFD) gained. Budesonide increased SFDs by an average of 14.1 days annually. From a healthcare payer perspective, budesonide would reduce the total cost of asthma care in Australia. In Sweden, Canada, France, Spain, UK, China and the USA, the ICER ranged from US$2.4-11.3 per SFD. From a societal perspective, budesonide would be cost-saving in Australia, Canada and Sweden. In conclusion, for countries where costs with budesonide are higher, the policy implication has to be determined by that health system's willingness to pay for an additional symptom-free day. However, where budesonide therapy increases symptom-free days and reduces total costs, the policy conclusion clearly favours early intervention. 相似文献